key: cord-0809754-3bcrkuel
authors: de la Villa, Sofía; Valerio, Maricela; Salcedo, Magdalena; Ortiz‐Bautista, Carlos; Catalán, Pilar; Padilla, Belén; Romero, Mario; Blázquez‐Bermejo, Zorba; Pedraz, Álvaro; López‐Baena, José Ángel; Hortal, Javier; Bouza, Emilio; Alonso, Roberto; Muñoz, Patricia
title: Heart and liver transplant recipients from donor with positive SARS‐CoV‐2 RT‐PCR at time of transplantation
date: 2021-06-06
journal: Transpl Infect Dis
DOI: 10.1111/tid.13664
sha: 49df7c67d0fafbaf63f39afa37661af835292c56
doc_id: 809754
cord_uid: 3bcrkuel

At present, there is unclear evidence on the need for a negative SARS‐CoV‐2 RT‐PCR for donors with a history of COVID‐19 prior to transplantation (1,2). We report two cases of heart and liver recipients from a donor with previous documented COVID‐19 and positive RT‐PCR at time of transplantation.

history of COVID-19 prior to transplantation 1,2 . We report two cases of heart and liver recipients from a donor with previous documented COVID-19 and positive RT-PCR at time of transplantation.

Donor: a 29-year-old woman with confirmed mild COVID-19 infection two months earlier was deceased due to subarachnoid hemorrhage. At time of explanting the organs, the patient had a positive SARS-CoV-2 RT-PCR in a nasopharyngeal swab (Ct 30) and serology with a titer of 954 AU/mL of anti-spike protein. All these tests were done in another institution. At time of organ extraction, a plasma SARS-CoV-2 RT-PCR was performed in our hospital and it was negative.

This article is protected by copyright. All rights reserved Heart recipient: a 66-year-old man with a dilated cardiomyopathy was admitted for elective heart transplant. Immunosuppression received was basiliximab, methylprednisolone, tacrolimus and mycophenolate mofetil. On day +8 the patient developed a severe pericardial effusion requiring drainage. 

SARS-CoV-2 assessment and screening in organ donors and recipients. In: Organ Donation and Transplantation